Taking advantage of the radiopharmaceutical revolution “We’re on the cusp of something really exciting,” says Jilly Croasdale, head of radiopharmacy at Sandwell and West Birmingham NHS Trust.  Over the past five years, there has been a surge in new…

*Taking advantage of the radiopharmaceutical revolution*

In our latest feature, #RachelBrazil looks into why experts are questioning whether the UK has the resources to ride the #radiopharmaceutical wave

#cancer #cancertreatment #oncology #radiopharmacy

LabConnect Collaborates with The Bracken Group to Enhance Radiopharmaceutical Support Services LabConnect has formed a strategic partnership with The Bracken Group to expand its radiopharmaceutical support services, meeting the rising demand in clinical trials.

LabConnect Collaborates with The Bracken Group to Enhance Radiopharmaceutical Support Services #USA #LabConnect #Johnson_City #Radiopharmaceutical #Bracken_Group

Theranostics Europe 2026

𝗧𝗵𝗲𝗿𝗮𝗻𝗼𝘀𝘁𝗶𝗰𝘀 𝗘𝘂𝗿𝗼𝗽𝗲 𝟮𝟬𝟮𝟲 - Bridging Science and Patient Care in Precision Oncology and Beyond

𝗥𝗲𝗴𝗶𝘀𝘁𝗲𝗿 𝗛𝗲𝗿𝗲: lnkd.in/eGSFq7nE

#theranosticseurope #Radionuclide #Radiopharmaceutical #Therapeuticisotopes #radiotheranostics #GlobalEngage

“Smart missile” radiopharmaceutical shows promise against multiple cancers A new cancer treatment that delivers radiation directly to tumors by targeting two key markers simultaneously has been shown to be safe and effective in human trials.

New research presented at the @snm-mi.bsky.social ‪annual meeting #SNMMI2025 makes a strong case for a new dual-targeting #radiopharmaceutical, designed to attach to two vulnerable sites on #cancer cells, enabling more precise and potent therapy. #nuclearmedicine

Nordic Capital and Minerva Imaging Join Forces to Transform the Radiopharmaceutical Market Nordic Capital has announced a partnership with Minerva Imaging, aimed at accelerating their growth in the radiopharmaceutical sector, enhancing patient care.

Nordic Capital and Minerva Imaging Join Forces to Transform the Radiopharmaceutical Market #Denmark #Nordic_Capital #Minerva_Imaging #Ølstykke #Radiopharmaceutical

For this story, we asked whether we could explore expression in patient samples (PDXs, PDOs, cell lines, IHC of tumors) more sytematically and whether we could use #GPC3 as a #radiopharmaceutical target for #NEPC.

Turns out that GPC3 is highly enriched in patients with AR-/NE+ prostate cancers!

Catch WSIC at #iSRS2025 !🌏 🇦🇺

◽Jonathan Cotton speaks on ⁶⁴Cu-labelled α-fucosidase for imaging #senescence 🧪☢️

◽Federica Bonanno shares a poster on α-synuclein #PET ligands🧠☢️

If you're attending, feel free to stop by!!

We look forward to engaging with the #radiopharmaceutical research community!

New #Professor 👉 The Faculty of Pharmacy recruits Luke Odell to our newly established Professorship in #Radiopharmaceutical #Chemistry, a strategic investment that will strengthen @uu.se's and the University Hospital's already prominent position in imaging ✅ www.uu.se/en/departmen...

A glimpse into my presentation, “Alpha Emitters and Where to Find Them”, for the Italian Group of #Radiopharmaceutical Chemistry - plus a personal, metaphorical take on the “alpha world” ☢️

Heaven 🪽 or Hell 🔥?

FDA grants Orphan Drug Designation to Ariceum cancer therapy - PharmaTimes Designation follows promising preclinical data and FDA clearance

#OrphanDrugDesignation #ODD #AriceumTherapeutics #systemictargetedradiotherapy#radiopharmaceuticalcancertherapy #radiopharmaceutical #225Acsatoreotide #SmallCellLungCancer #SCLC #SCLCpatients #SANTANA225clinialtrial #theranosticpair #targetedradionuclidetreatment
pharmatimes.com/news/fda-gra...

Radiology adjacent #radonc focused on #radiopharmaceutical development 👋🏽

NUKED: Access is everything, with GlyTherix and Telix Pharmaceuticals - Phase III In early 2023, one of the first two really big radiopharmaceutical drugs ran into a problem.  Novartis' prostate cancer therapy Pluvicto, released only the year before, was suddenly in short supply, s...

In episode 2 of NUKED we explore where biotechs get their hands on the nukes >> they’re making nuclear waste a social good
#biosky #radiopharmaceutical

NUKED: Why radiopharmaceuticals are exploding, with Peter MacCallum Cancer Centre and HB Biotechnology - Phase III The radiopharmaceuticals sector is on a knife point. The scope of what nuclear medicine can do is exploding. But the radioisotopes that biotechs need to make those therapies are in very, very short su...

And it's here: #radiopharmaceutical medicine is estimated to account for 60% of all cancer therapies by the end of decade. But biotechs have to set up side hustles in nuclear physics to make sure that happens 💫
#biosky #biotech #podcast

Fellow #radonc nerds:

I am putting some finishing (that's my story and I'm sticking to it) touches on my "Chemistry of #Radiopharmaceutical Therapy" lecture for #ASTRO Beyond The Beam Course.

What do you want to know about?